These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4011730)

  • 1. Opioid antagonist-induced regulation of organ development.
    Zagon IS; McLaughlin PJ
    Physiol Behav; 1985 Apr; 34(4):507-11. PubMed ID: 4011730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth.
    Zagon IS; McLaughlin PJ
    Life Sci; 1984 Nov; 35(20):2057-64. PubMed ID: 6092812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid antagonist (naltrexone) modulation of cerebellar development: histological and morphometric studies.
    Zagon IS; McLaughlin PJ
    J Neurosci; 1986 May; 6(5):1424-32. PubMed ID: 3711987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid antagonist-induced modulation of cerebral and hippocampal development: histological and morphometric studies.
    Zagon IS; McLaughlin PJ
    Brain Res; 1986 Aug; 393(2):233-46. PubMed ID: 3017514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone modulates growth in infant rats.
    Zagon IS; McLaughlin PJ
    Life Sci; 1983 Dec; 33(24):2449-54. PubMed ID: 6316064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone's influence on neurobehavioral development.
    Zagon IS; McLaughlin PJ
    Pharmacol Biochem Behav; 1985 Mar; 22(3):441-8. PubMed ID: 3991759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone modulates body and organ growth of rats: dependency on the duration of opioid receptor blockade and stereospecificity.
    Zagon IS; McLaughlin PJ
    Pharmacol Biochem Behav; 1989 Jun; 33(2):325-8. PubMed ID: 2554339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous opioid systems and the regulation of dendritic growth and spine formation.
    Hauser KF; McLaughlin PJ; Zagon IS
    J Comp Neurol; 1989 Mar; 281(1):13-22. PubMed ID: 2925898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased brain size and cellular content in infant rats treated with an opiate antagonist.
    Zagon IS; McLaughlin PJ
    Science; 1983 Sep; 221(4616):1179-80. PubMed ID: 6612331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naltrexone in postnatal rats on the recovery of disturbed brain and lymphatic tissues after X-irradiation or ethylnitrosourea treatment in utero.
    Schmahl WG; Plendl J; Reinöhl-Kompa S
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):89-99. PubMed ID: 3563109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone does not increase brain and body development in rats.
    Petrie BF
    Neurotoxicol Teratol; 1993; 15(4):275-7. PubMed ID: 8413082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic exposure to the opioid antagonist naltrexone during pregnancy: maternal and offspring effects.
    McLaughlin PJ; Tobias SW; Lang CM; Zagon IS
    Physiol Behav; 1997 Sep; 62(3):501-8. PubMed ID: 9272656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated administration of naltrexone and diprenorphine decreases food intake and body weight in squirrel monkeys.
    Herman BH; Holtzman SG
    Life Sci; 1984 Jan; 34(1):1-12. PubMed ID: 6319931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid antagonist modulation of rat heart development.
    McLaughlin PJ
    Life Sci; 1994; 54(19):1423-31. PubMed ID: 8190015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic naltrexone treatment increases the heroin-produced facilitation of self-stimulation.
    Schenk S; Nawiesniak E
    Pharmacol Biochem Behav; 1985 Feb; 22(2):175-7. PubMed ID: 2984700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of growth in young mice treated with pentazocine: reversal by naltrexone.
    Wassef NM; Smith AA
    Eur J Pharmacol; 1980 Aug; 66(2-3):155-60. PubMed ID: 6254782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic exposure to the opioid growth factor, [Met5]-enkephalin, during pregnancy: maternal and preweaning effects.
    McLaughlin PJ; Wylie JD; Bloom G; Griffith JW; Zagon IS
    Pharmacol Biochem Behav; 2002; 71(1-2):171-81. PubMed ID: 11812520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone.
    Critcher EC; Lin CI; Patel J; Myers RD
    Pharmacol Biochem Behav; 1983 Feb; 18(2):225-9. PubMed ID: 6835979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to the opioid antagonist naltrexone throughout gestation alters postnatal heart development.
    McLaughlin PJ
    Biol Neonate; 2002; 82(3):207-16. PubMed ID: 12373072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Mar; (539):1-266. PubMed ID: 18685713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.